The Vaccine Externality and its Impact on a Pharmaceutical Company.
dc.contributor.advisor | Stephen Margolis, Chair | en_US |
dc.contributor.advisor | Anita Brown-Graham, Member | en_US |
dc.contributor.advisor | Tamah Morant, Member | en_US |
dc.contributor.author | Bright, Justin Michael | en_US |
dc.date.accepted | 2012-04-16 | en_US |
dc.date.accessioned | 2012-04-18T05:35:09Z | |
dc.date.available | 2012-04-18T05:35:09Z | |
dc.date.defense | 2012-03-29 | en_US |
dc.date.issued | 2012-03-29 | en_US |
dc.date.released | 2012-04-18 | en_US |
dc.date.reviewed | 2012-03-30 | en_US |
dc.date.submitted | 2012-03-30 | en_US |
dc.degree.discipline | Economics | en_US |
dc.degree.level | thesis | en_US |
dc.degree.name | Master of Science | en_US |
dc.identifier.other | deg1642 | en_US |
dc.identifier.uri | http://www.lib.ncsu.edu/resolver/1840.16/7670 | |
dc.rights | en_US | |
dc.title | The Vaccine Externality and its Impact on a Pharmaceutical Company. | en_US |
Files
Original bundle
1 - 1 of 1